Kemnay Advisory Services’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
Kemnay Advisory Services's TVTX Position: Q2 2026 in Review
Kemnay Advisory Services increased its Travere Therapeutics (TVTX) stake by 10% in Q2 2026, buying an estimated $3.41K and bringing the position to 830 shares worth $47.2K. The position accounts for 0.01% of the portfolio, ranked #320.
Kemnay Advisory Services first reported a position in TVTX in Q1 2026 and has held it in 2 quarters since. 322 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.
- Kemnay Advisory Services held 830 shares of Travere Therapeutics worth $47.2K as of Q2 2026.
- Kemnay Advisory Services bought 77 Travere Therapeutics shares in Q2 2026, an estimated $3.41K.
- Travere Therapeutics made up 0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #320 holding.
- Kemnay Advisory Services first reported a position in Travere Therapeutics in Q1 2026 and has held it in 2 quarters since.
- 322 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.
Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.